$431.65
4.65% today
NYSE, Apr 04, 07:15 pm CET
ISIN
US0367521038
Symbol
ELV

Elevance Health Target price 2025 - Analyst rating & recommendation

Elevance Health Classifications & Recommendation:

Buy
75%
Hold
21%
Sell
4%

Elevance Health Price Target

Target Price $485.67
Price $452.69
Potential
Number of Estimates 18
18 Analysts have issued a price target Elevance Health 2026 . The average Elevance Health target price is $485.67. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 24 analysts: 18 Analysts recommend Elevance Health to buy, 5 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Elevance Health stock has an average upside potential 2026 of . Most analysts recommend the Elevance Health stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion $ 176.81 192.89
3.19% 9.09%
Net Margin 3.30% 3.78%
1.33% 14.41%

16 Analysts have issued a sales forecast Elevance Health 2025 . The average Elevance Health sales estimate is

$193b
Unlock
. This is
9.09% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$196b 10.91%
Unlock
, the lowest is
$191b 7.84%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $177b 3.19%
2025
$193b 9.09%
Unlock
2026
$207b 7.18%
Unlock
2027
$222b 7.43%
Unlock
2028
$241b 8.60%
Unlock
2029
$273b 13.11%
Unlock

9 Elevance Health Analysts have issued a net profit forecast 2025. The average Elevance Health net profit estimate is

$7.3b
Unlock
. This is
25.08% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$7.9b 35.22%
Unlock
, the lowest is
$6.5b 10.74%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $5.8b 1.82%
2025
$7.3b 24.74%
Unlock
2026
$8.4b 14.69%
Unlock
2027
$9.8b 17.19%
Unlock
2028
$11.3b 15.27%
Unlock
2029
$12.9b 14.25%
Unlock

Net Margin

2024 3.30% 1.33%
2025
3.78% 14.41%
Unlock
2026
4.04% 6.88%
Unlock
2027
4.41% 9.16%
Unlock
2028
4.68% 6.12%
Unlock
2029
4.73% 1.07%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 25.68 32.03
1.82% 24.73%
P/E 14.13
EV/Sales 0.66

9 Analysts have issued a Elevance Health forecast for earnings per share. The average Elevance Health EPS is

$32.03
Unlock
. This is
25.07% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$34.63 35.22%
Unlock
, the lowest is
$28.36 10.74%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $25.68 1.82%
2025
$32.03 24.73%
Unlock
2026
$36.74 14.70%
Unlock
2027
$43.06 17.20%
Unlock
2028
$49.63 15.26%
Unlock
2029
$56.70 14.25%
Unlock

P/E ratio

Current 17.68 14.17%
2025
14.13 20.08%
Unlock
2026
12.32 12.81%
Unlock
2027
10.51 14.69%
Unlock
2028
9.12 13.23%
Unlock
2029
7.98 12.50%
Unlock

Based on analysts' sales estimates for 2025, the Elevance Health stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.72 12.20%
2025
0.66 8.71%
Unlock
2026
0.61 6.69%
Unlock
2027
0.57 6.91%
Unlock
2028
0.53 7.92%
Unlock
2029
0.46 11.60%
Unlock

P/S ratio

Current 0.58 17.33%
2025
0.53 8.33%
Unlock
2026
0.50 6.71%
Unlock
2027
0.46 6.91%
Unlock
2028
0.43 7.92%
Unlock
2029
0.38 11.58%
Unlock

Current Elevance Health Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Argus Research
Locked
Locked
Locked Jan 29 2025
Wells Fargo
Locked
Locked
Locked Jan 28 2025
Cantor Fitzgerald
Locked
Locked
Locked Jan 24 2025
Barclays
Locked
Locked
Locked Jan 24 2025
Truist Securities
Locked
Locked
Locked Jan 06 2025
Mizuho
Locked
Locked
Locked Nov 05 2024
Wells Fargo
Locked
Locked
Locked Nov 04 2024
Analyst Rating Date
Locked
Argus Research:
Locked
Locked
Jan 29 2025
Locked
Wells Fargo:
Locked
Locked
Jan 28 2025
Locked
Cantor Fitzgerald:
Locked
Locked
Jan 24 2025
Locked
Barclays:
Locked
Locked
Jan 24 2025
Locked
Truist Securities:
Locked
Locked
Jan 06 2025
Locked
Mizuho:
Locked
Locked
Nov 05 2024
Locked
Wells Fargo:
Locked
Locked
Nov 04 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today